Floatz logo

gc203 til

Gastrointestinal Cancer

Shanghai Juncell TherapeuticsCell therapyPhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

39 Active assets in the Gastrointestinal Cancer cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Alliance for Clinical Trials in Oncology
Phase 2BB
FLUOROURACILUM
Alliance for Clinical Trials in Oncology
Phase 2BB
Eloxatin
Alliance for Clinical Trials in Oncology
Phase 2BB
Irinotecan
Amgen
Phase 2BB
DEXAMETHASONE
Cedars-Sinai Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

gc203 til is also rated in:

Solid Tumors, AdultDormant
CC
Indicative ·
43 / 100
View asset →
Gynecologic CancerDormant
CC
Indicative ·
41 / 100
View asset →
Tumor Infiltrating LymphocytesDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →